Having repurchased 23 million shares, or $1 billion worth of company stock, in the second quarter, oil services giant Halliburton (NYSE: HAL ) announced today it had approved an increase to $5 billion in its buyback program.
The board of directors said that with just�$0.7 billion of repurchasing capacity remaining on the existing authorization that was initiated in 2006, it would increase by another $4.3 billion its ability to buy back shares. It also declared its third-quarter dividend of $0.125 per share, the same rate it's paid for the last two quarters after having increased the payout 39% from $0.09 per share.
Noting the first-quarter dividend hike reflected management's increased confidence in the strength of the company's outlook, Halliburton Chairman, President, and CEO�Dave Lesar said, "We believe that our relentless focus on generating best-in-class returns and our commitment to shareholder distributions will deliver increased value to our shareholders going forward."
Top 5 Diversified Bank Companies To Watch In Right Now: Etablissements Maurel et Prom SA (MAU)
Etablissements Maurel et Prom SA is a France-based company engaged in the exploration and production of hydrocarbons (oil and gas), and in oil drilling activities. Its main activities comprise geological surveys, seismic acquisition and processing, geophysical interpretation and drilling. The Company pursues its activities mainly in Africa and Latin America, but it also has its businesses in Gabon, Senegal, Congo, Mozambique, Syria, Tanzania, Colombia, Peru, Venezuela, France and Italy. Maurel & Prom SA operates through its direct and indirect subsidiaries, including M&P Venezuela SAS, Prestoil Kouilou, Maurel & Prom Peru Holdings, Maurel & Prom Tanzanie Ltd and Panther Eureka SRL, among others. In December, 2013, the Company the acquisition of all of the shares of Caroil SAS (excluding the South American business of Caroil) from Tuscany International Drilling Inc. and has sold all of its 109,000,000 common shares of Tuscany to an entity incorporated in the Cayman Islands. Advisors' Opinion:- [By Riddhi Kharkia]
Since I have touched the topic of metrics, it is worthwhile to note that Twitter�� monthly active users (MAU) number stands at 57 million as compared to approximately 1.23 billion MAUs for Facebook. Monthly active user growth ticked up just 6% for Twitter on a sequential basis, while monthly active users fell 8% year over year. Even in terms of quarterly results, Facebook was miles ahead of Twitter, which was also a factor behind the sell-off in Twitter stock.
Top 10 Oil Service Companies To Watch In Right Now: Etablissementen Fr Colruyt NV (COLR)
Etablissementen Fr Colruyt NV, also known as Colruyt Group, is a Belgian company primarily engaged in retail and wholesale of food products. The Company's retail trade division includes the direct supply of products to retail customers operating through brands Colruyt, DreamBaby, BIO-planet, DreamLand and ColliShop, among others. The Company supplies to wholesalers and affiliated independent merchants in Belgium, France and Luxembourg. It also provides printing solutions (photo Fuji Colruyt). Colruyt Group also has a corporate activities division, which combines support services, processes and systems and central administration, among others. Advisors' Opinion:- [By Tom Stoukas]
Colruyt SA (COLR) fell 4 percent to 42.31 euros. Belgium�� largest discount food retailer forecast full-year net income of about 369 million euros ($498 million) compared with analysts�� estimates of 381.2 million euros.
Top 10 Oil Service Companies To Watch In Right Now: Microchip Technology Incorporated(MCHP)
Microchip Technology Incorporated, together with its subsidiaries, develops, manufactures, and sells semiconductor products for various embedded control applications. It offers a family of microcontroller products that include 8-bit, 16-bit, and 32-bit PIC microcontrollers; and 16-bit dsPIC digital signal controllers, which feature on-board flash memory technology. The company also provides a set of application development tools that enable system designers to program a PIC microcontroller and dsPIC DSC for specific applications. In addition, it offers analog and interface products, which consist of various families with approximately 600 power management, linear, mixed-signal, thermal management, safety and security, and interface products. Further, the company provides memory products comprising serial electrically erasable programmable read-only memory. Its products are used in various applications in automotive, communications, computing, consumer, and industrial contr ol markets. Microchip Technology Incorporated markets its products primarily through a network of direct sales personnel and distributors in the Americas, Europe, and Asia. The company was founded in 1989 and is based in Chandler, Arizona.
Advisors' Opinion:- [By Srdjan Bejakovic]
In the first quarter, semiconductor maker Atmel� (NASDAQ: ATML ) recorded $337 million in revenue, $7 million above the upper end of its own guidance range. Additionally, management claims that 2014 will be a year of growth and increased profitability for the company, driven by continuing demand for microcontrollers and an improving picture in Atmel's touch business. What's lying behind the surprising revenue numbers, and can Atmel prosper in spite of increasing competition from such solid companies as Microchip Technologies� (NASDAQ: MCHP ) and Synaptics (NASDAQ: SYNA ) ?
Top 10 Oil Service Companies To Watch In Right Now: BG Group PLC (BRGYY.PK)
BG Group plc (BG Group), incorporated on December 30, 1998, is a natural gas company. The Company is engaged in the exploration, development and production of natural gas and oil. he Company operates in two business segments: Exploration and Production (E&P) and Liquefied Natural Gas (LNG). The Company manages its business on an integrated basis across the Americas, Europe, Africa, Central and South Asia, and Australia. The Company has interests in more than 20 countries on five continents.
Exploration and Production
E&P consists of exploration, development, production and marketing of hydrocarbons with a focus on natural gas. BG Group�� Upstream segment covers exploration and production activities for gas, oil and liquids, plus liquefaction operations associated with integrated LNG projects.
Liquefied Natural Gas
BG Group�� LNG activities combine liquefaction and regasification facilities with the purchasing, shipping, marketing and sale of LNG. The Company has interest in liquefaction facilities in Egypt and Trinidad and Tobago. BG Group�� LNG Shipping & Marketing segment covers the purchasing, shipping, marketing and sale of LNG, as well as the Group�� interests and capacity in regasification facilities.
Advisors' Opinion:- [By Heather Ingrassia]
On Thursday, August 15, GasLog (GLOG) announced that it had ordered two new 174K cbm Tri-Fuel Diesel Electric LNG carriers from Samsung Heavy Industries. These carriers are expected to be delivered in 2016 which is the same year the company will begin seven-year charters with BG Group (BRGYY.PK) (BRGXF.PK).
Top 10 Oil Service Companies To Watch In Right Now: Comtech Telecommunications Corp.(CMTL)
Comtech Telecommunications Corp. engages in the design, development, production, and marketing of products, systems, and services for advanced communications solutions in the United States and internationally. It operates in three segments: Telecommunications Transmission, Mobile Data Communications, and RF Microwave Amplifiers. The Telecommunications Transmission segment provides satellite earth station equipment and systems, over-the-horizon microwave systems, and forward error correction technology, which are used in various commercial and government applications, including backhaul of wireless and cellular traffic, broadcasting (including HDTV), IP-based communications traffic, long distance telephony, and secure defense applications. The Mobile Data Communications segment provides mobile satellite transceivers, and computers and satellite earth station network gateways and associated installation, training, and maintenance services; supplies and operates satellite pac ket data networks, including arranging and providing satellite capacity; and offers microsatellites and related components. The RF Microwave Amplifiers segment designs, develops, manufactures, and markets satellite earth station traveling wave tube amplifiers (TWTA) and broadband amplifiers. Its amplifiers are used in broadcast and broadband satellite communication; defense applications, such as telecommunications systems and electronic warfare systems; and commercial applications comprising oncology treatment systems, as well as to amplify signals carrying voice, video, or data for air-to-satellite-to-ground communications. The company serves satellite systems integrators, wireless and other communication service providers, broadcasters, defense contractors, military, governments, and oil companies. Comtech markets its products through independent representatives and value-added resellers. The company was founded in 1967 and is headquartered in Melville, New York.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Comtech Telecommunications (Nasdaq: CMTL ) , whose recent revenue and earnings are plotted below. - [By Rich Smith]
Maybe there's something to this whole "sequestration" phenomenon after all -- because for all intents and purposes -- and certainly in comparison with recent trends -- Department of Defense spending has come to a screeching halt in recent days. On Wednesday, for example, DoD issued a grand total of three new contracts, totaling a mere Pentagon pittance of just $44.4 million.
- [By Tim Melvin]
Comtech Telecommunications (CMTL) is another company with a solid dividend whose shares trade at a decent price. The company makes advanced telecommunication products and sells to a wide range of users, including satellite systems integrators, wireless providers, broadcasters and defense contractors — as well as the U.S. government. The company has seen some weakness as military and government orders have slowed and the marketplace remains very competitive, but the long-term outlook is pretty strong. The company has been actively buying back stock and has spent almost $25 million in purchases in the past nine months. Comtech has more than enough cash on hand and very little debt, so the balance sheet is solid and the stock yields 4.5% right now. The company should be able to increase the dividend at a double-digit pace for the next several years at least.
- [By Wallace Witkowski]
Shares of Comtech Telecommunications Corp. (CMTL) �rose 6.2% to $33.24 on moderate volume after the company beat Wall Street estimates for the fiscal first quarter and raised its guidance.
Top 10 Oil Service Companies To Watch In Right Now: BioTime Inc (BTX)
BioTime, Inc., incorporated on November 30, 1990, is a biotechnology company focused on the emerging field of regenerative medicine. Its commercial strategy is focused on its line of research products, such as ACTCellerate cell lines and associated ESpan culture media, HyStem hydrogels, human embryonic stem (hES) cell lines, and royalties from Hextend. Its focus is to provide regenerative therapies for age-related degenerative diseases. In January 2011, the Company acquired the assets of Cell Targeting, Inc. (CTI), a biotechnology company focused on methods of painting molecules on the surface of cells, which in turn causes the cells to adhere to particular tissues, such as those afflicted with disease. On March 21, 2011, the Company acquired Glycosan BioSystems, Inc. (Glycosan) through a merger of Glycosan with OrthoCyte Corporation (OrthoCyte). Through the merger, OrthoCyte acquired all of Glycosan�� assets, including Glycosan�� Hystem hydrogel product line. In March 2011, the Company entered into an agreement with XenneX, Inc., pursuant to which it organized LifeMap Sciences, Inc. (LifeMap), a subsidiary formed to advance the development and commercialization of its human embryonic stem (hES) cell data base. In August 2011, four hES cell lines (ESI-035, ESI-049, ESI-051 and ESI-053) developed by its subsidiary ES Cell International (ESI) were approved by the National Institutes of Health (NIH) for inclusion in the NIH Human Embryonic Stem Cell Registry. In May 2012, the Company acquired XenneX, Inc., through a merger of XenneX into LifeMap Sciences. In September 2012, the Company formed a wholly owned subsidiary, BioTime Acquisition Corporation. In October 2013, Geron Corporation announced the closing of the transaction to divest the Company's stem cell assets to Asterias Biotherapeutics, Inc., a subsidiary of BioTime, Inc.
HyStem is a biomaterial, which mimics the human extracellular matrix, which is the network of molecules surrounding cells in organs and tissues which is essent! ial to cellular function. Its HyStem hydrogels may have other applications when combined with the diverse and scalable cell types its scientists have isolated from hES cells. HyStem-Rx is a clinical grade formulation of HyStem-C, a biocompatible, implantable hyaluronan and collagen-based matrix for cell delivery in human clinical applications. Its subsidiary, OncoCyte Corporation, is developing PanC-Dx, a non-invasive blood-based cancer screening test designed to detect the presence of various human cancers, including cancers of the breast, lung, bladder, uterus, stomach, and colon, during routine check -ups. BioTime Asia, Limited (BioTime Asia) sells products for research use and may develop therapies to treat cancer and neurological and orthopedic diseases in Asia. OrthoCyte Corporation (OrthoCyte) is developing therapies to treat orthopedic disorders, diseases and injuries. ReCyte Therapeutics, Inc. (ReCyte Therapeutics) is developing therapies for age-related cardiovascular and blood disorders. Cell Cure Neurosciences Ltd. (Cell Cure Neurosciences), is a biotechnology company focused on developing stem cell-based therapies for retinal and other neurological disorders, including the development of retinal pigment epithelial (RPE) cells for the treatment of age-related macular degeneration. LifeMap Sciences, Inc. (LifeMap) is advancing the development and commercialization of our embryonic stem cell database and plans to make the database available for the marketing of research products and for use by stem cell researchers at pharmaceutical and biotechnology companies and other institutions via paid subscriptions or on a fee per use basis.
The Company�� blood plasma expander product, Hextend, is a physiologically balanced intravenous solution used in the treatment of hypovolemia, a condition caused by low blood volume, often from blood loss during surgery or injury. Hextend maintains circulatory system fluid volume and blood pressure, and keeps vital organs perfused during surgery and t! rauma car! e. Hextend is manufactured and distributed in the United States by Hospira, Inc., and in South Korea by CJ CheilJedang (CJ), under license from it.
Human Embryonic Stem Cell Lines for Research Use
Combined with the Company�� ACTCellerate technology, it derives of a range of markets human embryonic progenitor cells (hEPCs). ESI�� six current good manufacturing practices (cGMP) hES cell lines have been approved by the NIH for inclusion in the Human Embryonic Stem Cell Registry, which renders those cell lines eligible for use in federally funded research. The ESI hES cell lines are available for purchase through www.biotimeinc.com. It also markets hEPCs developed using ACTCellerate technology. Its hEPCs are also available for sale through www.biotimeinc.com. It derived the complete genome sequence of five of the ESI hES cell lines to facilitate the development of products derived from these cell lines. It has made these GMP-grade cell lines, along with certain documentation and complete genomic deoxyribonucleic acid (DNA) sequence information, available for sale.
The Company offers human stem cell products and technology that can be used by researchers at universities and at companies in the bioscience and biopharmaceutical industries. It has developed research and clinical grade hES cell lines, which it markets for both basic research and therapeutic product development. It also markets human embryonic progenitor cell (hEPCs) developed using ACTCellerate technology. These hEPCs are purified lineages of cells, which are intermediate in the developmental process between embryonic stem cells and fully differentiated cells. The ACTCellerate cell lines are also available for purchase through http://www.biotimeinc.com.
Human Embryonic Progenitor Cells
Through the Company�� subsidiary ReCyte Therapeutics, it had a license from Advanced Cell Technology, Inc. (ACT) to use ACTCellerate technology, and the rights to market more than 200 human c! ell types! made using that process. ACTCellerate allows the rapid isolation of hEPCs, which are cells that are intermediate in the developmental process between embryonic stem cells and fully differentiated cells.
Through an agreement with ReCyte Therapeutics, Millipore Corporation became a global distributor of ACTCellerate hEPC lines. In addition to the products, which it is co-marketing with Millipore, it offers 92 other ACTCellerate hEPC lines for purchase at www.biotimeinc.com. Through its subsidiary LifeMap, it provides online biomedical database services to increase awareness of molecular markers and diverse cell types comprising its ACTCellerate hEPC lines. It also focuses to market additional cell types manufactured with its PureStem technology. PureStem cell lines are produced by the exogenous expression of specific transcription factors, which regulate the differentiation of cell types from hES or induced pluripotent stem (iPS) cells. BioTime Asia has an agreement with Shanghai Genext Medical Technology Co., Ltd. to sell ACTCellerate hEPC lines and related ESpan growth media to the medical and biological research communities in China, Taiwan, Hong Kong, and Macau on an exclusive basis. The marketing agreement includes provisions for an initial stocking inventory and annual milestones to maintain exclusivity. The Company�� California Institute of Regenerative Medicine (CIRM)-funded research addresses the need for industrial scale production of purified therapeutic cells.
hES Cells Carrying Genetic Diseases
The Company focuses to add to its product line muscle progenitor cells produced from five hES cell lines carrying genes for Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, spinal muscular atrophy Type I, facioscapulohumeral muscular dystrophy 1A, and Becker muscular dystrophy. It obtained the diseased hES cell lines from Reproductive Genetics Institute (RGI).
ESpan Cell Growth Media
The Company is marketing a range of! cell-gro! wth media products called ESpan. These growth media are optimized for the growth of hEPC types. Cells need to be propagated in liquid media, in both the laboratory setting, where basic research on stem cells is performed, and in the commercial sector. Its ESpan products are marketed through Millipore and Genext.
ESpy Cell Lines
The Company focuses for development of ESpy cell lines. The ability of the ESpy cells to emit light will allow researchers to track the location and distribution of the cells in both in vitro and in vivo studies.
HyStem Hydrogel for Research and HyStem-Rx for Cell Delivery Medical Devices
HyStem is a patented biomaterial that mimics the ECM, the network of molecules surrounding cells in organs and tissues that is essential to cellular function. Its HyStem technology forms the foundation for stem cell delivery products in both the adult and embryonic stem cell marketplace, including products manufactured using its ACTCellerate technology. As an injectable product, HyStem-Rx may address need in cosmetic and reconstructive surgeries and other procedures by transplanting adipose derived cells or other adult stem cells. The transfer of cells in HyStem-Rx localizes the transplanted cells at the intended site and by providing a three-dimensional scaffold upon which cells can rebuild normal tissue. HyStem-Rx may support other emerging cell and tissue transplant therapies, such as those derived from hES and iPS cells, in addition to its potential application in the treatment of a range of conditions such as osteoarthritis, brain tumors, stroke, bone fracture, and wounds.
Advisors' Opinion:- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biotechnology company BioTime (NYSEMKT: BTX ) has received the dreaded one-star ranking.
Top 10 Oil Service Companies To Watch In Right Now: Indochine Mining Ltd (IDC)
Indochine Mining Limited is an Australia-based company developing and discovering gold and silver projects. The Company�� flagship asset is the Mt Kare gold-silver project in the highlands of Papua New Guinea (PNG). Mt Kare gold-silver project is held through its wholly owned PNG subsidiary, Summit Development Limited. The deposit lies 15 kilometers from the giant Porgera gold mine, which contains approximately 30 million ounces of gold. The Company holds two packages of exploration leases in Cambodia with potential for the discovery of gold and copper deposits. The Company�� projects in Cambodia include Kratie and Ratanakiri. Its subsidiaries include Indochine Resources Limited, Indochine Resources (Cambodia) Limited, Asia Pacific Gold & Copper Company Limited, Asia Pacific Gold & Copper (Cambodia) Limited, Aries Mining Limited, Summit Development Ltd and Positive Developments Limited. Advisors' Opinion:- [By Bill Smith]
FDS operates in a highly competitive industry, some with more resources. Their competitors include:
Thomson Reuters Corp. (TRI)BloombergInteractive (IDC)MSCI Inc. (MXB)Morningstar Inc. (MORN)Track Data Corp. (TRAC)Edgar Online (EDGR)McGraw-Hill (MHP ) - [By Analyse360Degree]
On Thursday, International Data Corporation (IDC) came out with its 2014 First Quarter Worldwide Quarterly Tablet Tracker and shed some light on the ongoing trends in the global tablet market. The figures reported by the data giant, though not very encouraging, were strong enough to bring smile on the faces of some tablet manufacturers, but Apple (AAPL), forcing us to think if this particular consumer electronic space is getting sour for the tech giant. Let�� take a look at what�� going on.
No comments:
Post a Comment